Srs Capital Advisors, Inc. Cor Medix Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 31 shares of CRMD stock, worth $250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31Holding current value
$250% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRMD
# of Institutions
101Shares Held
16.9MCall Options Held
70.5KPut Options Held
358K-
Black Rock Inc. New York, NY3.55MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$23.5 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl1.55MShares$12.5 Million0.04% of portfolio
-
Nomura Holdings Inc Tokyo, M01.42MShares$11.5 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.27MShares$10.3 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $333M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...